March 12 | 2018 2cureX inbjudna att presentera IndiTreat® och klinisk data på ESMO i juni 2018 Read more
January 22 | 2018 2cureX avtalar om de slutliga villkoren gällande ett bidrag om 29 MSEK från Horizon 2020 Read more
January 22 | 2018 2cureX agrees on final terms concerning an EUR 3 million grant from Horizon 2020 Read more
December 11 | 2017 Stort intresse för den nyligen inledda kliniska studien med 2cureX:s IndiTreat™-test Read more
December 11 | 2017 Large interest in the newly launched clinical trial for 2cureX’s IndiTreat™ test Read more
November 29 | 2017 2cureX prepares for market launch of IndiTreat™ in 2020 – international Chief Business Officer is recruited to lead the process Read more
November 2 | 2017 2cureX AB: rights issue ahead of the planned listing on the Nasdaq OMX Stockholm First North was heavily oversubscribed Read more
November 2 | 2017 2cureX AB: Nyemissionen inför planerad notering på Nasdaq Stockholm First North kraftigt övertecknad Read more